Michael Magnani Form
Michael Magnani is a seasoned healthcare executive bringing over 20 years of experience driving strategy, operations, and commercialization across the biotechnology, pharmaceutical, and medical device industries to our clients.
Prior to joining Kinsella Group, Mr. Magnani led high-impact initiatives spanning business development, product innovation, and go-to-market execution for both early-stage ventures and large public companies. He excels at building cross-functional teams, launching breakthrough technologies, and positioning companies for strategic growth and exit.
Most recently, Mr. Magnani served as President of CLS Americas, the U.S. subsidiary of Clinical Laserthermia Systems (Nasdaq: CLS-B.ST), where he oversaw domestic operations across Neurosurgical and Urological divisions. Prior to CLS, he was the founding CEO of two MedTech startups—Saranas and StimAire. Saranas was acquired in 2022 by Johnson & Johnson’s Abiomed division. StimAire is currently raising a Series B round following a successful pilot study in Australia, targeting a commercial launch in the sleep apnea space.
Earlier in his career, Mr. Magnani held leadership roles at large, publicly traded companies, managing teams and strategic initiatives across multiple business units and geographies.
Mr. Magnani holds an MS in Health Sciences & Technology from Harvard Medical School, an MBA from the MIT Sloan School of Management, and a BS in Microbiology from the University of California, San Diego, and remains actively involved in the MedTech ecosystem.